Building on a historic March 2026 meeting between Make America Healthy Again and chiropractic leadership, MAHA has announced the launch of the MAHA Chiropractic Hub, “a coordinated national partnership uniting MAHA Center, MAHA Action, and the chiropractic profession, including national associations, state organizations, practitioners, educators, researchers, and patient advocates. The Chiropractic Hub will advance federal policy, expand patient access, and build broad public support for chiropractic care across America.”
| Digital Exclusive"No Benefit from Amoxicillan"
A randomized double blind clinical trial of children ages 3-6 recently released from the Agency for Health Care Policy and Research (AHCPR), concluded that "there was no benefit from amoxicillan prophylaxis compared to a placebo control in preventing new AOM (acute otitis media) episodes."
Free of AOM (%)
30-90 Days:
Placebo Group:71% Otitis Free
Daily Amoxicillan Group: 65% Otitis Free
Twice Daily Amoxicillan Group: 62% Otitis Free
3 Months or Longer:
Placebo Group:54% Otitis Free
Daily Amoxicillan Group: 63% Otitis Free
Twice Daily Amoxicillan Group: 60% Otitis Free
SOURCE: Berman S. Continuous twice daily or once daily amoxicillan prophylaxis compared to placebo for children with recurrent otitis media. Agency for Health Care Policy and Research grant no.: RO3 HS07283-02.